Schedule 13G ownership disclosure

CHIMERIX INC

Security class unavailable · CUSIP: 16934W106

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-027011
Form type
SC 13G/A
Filer
CANTEX PHARMACEUTICALS, INC.
CIK
CIK 1374961
Filed
Feb 03, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub